Bulkamid for Stress Urinary Continence

May 18, 2021

Ellerkmann_Labcoat_Headshot_Indoors_Staircase_12.12.2016_ggp121116_0396.jpg

There is a new Food and Drug Administration-approved treatment for stress urinary incontinence.

The office-based procedure is used to quickly and effectively treat urinary stress incontinence in women, which results in leakage with activity such as coughing, sneezing and exercise.

According to Dr. R. Mark Ellerkmann, Director of The Urogynecology Center in the Institute for Gynecologic Care at Mercy, a procedure using “Bulkamid" can stop all of that.

"Bulkamid is a biodegradable gel that is injected as an out-patient procedure right in the office under local anesthesia to close the bladder neck so women don't leak with activity," Dr. Ellerkmann said.

Dr. Ellerkmann explained that some patients experience 80% or 90% improvement, and then they come back for a topping off procedure where a little more gel is injected at the bladder neck. It is done under local anesthesia and typically it takes about five to 10 minutes.

To view Mercy urogynecologist Dr. R. Mark Ellerkmann’s interview regarding Bulkamid for stress urinary incontinence, click here.

About Mercy

Founded in 1874 in Downtown Baltimore by the Sisters of Mercy, Mercy Medical Center is a 183-licensed bed, acute care, university-affiliated teaching hospital. Mercy has been recognized as a high-performing Maryland hospital (U.S. News & World Report); has achieved an overall 5-Star quality, safety, and patient experience rating (Centers for Medicare and Medicaid Services); is A-rated for Hospital Safety (Leapfrog Hospital Safety Grade); and is certified by the American Nurses Credentialing Center as a Magnet™ hospital. Mercy Health Services is a not-for-profit health system and the parent company of Mercy Medical Center and Mercy Personal Physicians.

Media Contact 
Dan Collins, Senior Director of Media Relations
Office: 410-332-9714
Cell: 410-375-7342
Email: dcollins@mdmercy.com

BuntingAtSunset---DSC_0765.jpg